Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.49 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.39 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | KCND3 | Q9UK17 | 1/20 | 0.39 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 7/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 7/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6051160 | 0.95 | ABCB1 (0.51) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL6051158 | 0.95 | ABCB1 (0.51) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL13631247 | 0.93 | ABCB1 (0.43) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL13631052 | 0.93 | ABCB1 (0.52) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL14996234 | 0.93 | ABCB1 (0.52) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL13617983 | 0.93 | ABCB1 (0.52) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL13631248 | 0.93 | ABCB1 (0.50) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL14996225 | 0.93 | ABCB1 (0.50) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL13617758 | 0.92 | ABCB1 (0.47) | ABCB1KCNE1KCNQ1KCNH2SCN5A | |
| SCHEMBL6051075 | 0.92 | ABCB1 (0.49) | ABCB1KCNE1KCNQ1KCNH2SCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455497-B2 | Inhibitors of aspartyl protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-06-04 | — | — | US | disclosed |
| US-20090274650-A1 | INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274650-A1 | INHIBITORS OF ASPARTYL PROTEASE | SPINT2, DNPEP, PRSS1 | ABCB1 628/4885KCNE1 3515/4885KCNQ1 3090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.